There is a need for surveillance of COVID-19 to identify individuals infected with
SARS-CoV-2 coronavirus. Although specific, nucleic acid testing has limitations in terms
of point-of-care testing. One potential alternative is the nonstructural protease (nsp5,
also known as M
pro
/3CL
pro
) implicated in SARS-CoV-2 viral
replication but not incorporated into virions. Here, we report a divalent substrate with
a novel design,
(Cys)
2
–(AA)
x
–(Asp)
3
,
to interface gold colloids in the specific presence of M
pro
leading to a
rapid and colorimetric readout. Citrate- and tris(2-carboxyethyl)phosphine (TCEP)-AuNPs
were identified as the best reporter out of the 17 ligated nanoparticles. Furthermore,
we empirically determined the effects of varying cysteine valence and biological media
on the sensor specificity and sensitivity. The divalent peptide was specific to
M
pro
, that is, there was no response when tested with other proteins or
enzymes. Furthermore, the M
pro
detection limits in Tris buffer and exhaled
breath matrices are 12.2 and 18.9 nM, respectively, which are comparable to other
reported methods (i.e., at low nanomolar concentrations) yet with a rapid and visual
readout. These results from our work would provide informative rationales to design a
practical and noninvasive alternative for COVID-19 diagnostic testing—the
presence of viral proteases in biofluids is validated.